Medroxyprogesterone acetate compositions

Details Medroxyprogesterone acetate compositions Medroxyprogesterone acetate compositions

1976-03-29

1977-07-26

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

A61K 3156

Patent

active

040383890

ABSTRACT:
A pharmaceutical vehicle for parenteral administration of medroxyprogesterone acetate is disclosed comprising an aqueous solution of sodium sulfate, quaternary ammonium wetting agent, and a member selected from glycerin, propylene glycol, polyethylene glycol, and polypropylene glycol. The compositions may contain a non-ionic hydrophilic colloid as a preferred adjuvant. Compositions are useful for suspending large amounts, e.g., from 200 to 600 mg./ml. of medroxyprogesterone acetate and maintaining suitable suspendability and syringeability characteristics and are used for the known therapeutic indications for medroxyprogesterone acetate.

REFERENCES:
patent: 3008875 (1961-11-01), Dale
patent: 3147290 (1964-09-01), Spero
American Pharmacy, pp. 97-103 - Lyman (1941).

Affiliated with

Also associated with

Rating

Medroxyprogesterone acetate compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medroxyprogesterone acetate compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medroxyprogesterone acetate compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-726821